Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium-free Icodextrin/Dextrose in Peritoneal Dialysis
NCT05185999Phase 1Completed
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of icodextrin and dextrose in chronic kidney disease (CKD). Primary endpoints: Adverse Events at 9 hours, Blood Pressure at 9 hours and 6 more. Started Oct 2022; status: completed.
02
Drugs
icodextrindextrose
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05185999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05185999.